4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one

C88H89N23O7 — CID 123274749

IUPAC4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one
SMILESCC(=O)Cc1cccc(-c2nc(N3CCOCC3)nc3c2ncn3-c2ccccc2)c1.Oc1cccc(-c2nc(N3CCOCC3)nc3c2ncn3C2CCCCO2)c1.c1ccc(Cn2cnc3c(-c4ccc5[nH]ccc5c4)nc(N4CCOCC4)nc32)cc1.c1nc2ccc(-c3nc(N4CCOCC4)nc4c3ncn4CC3CC3)cc2[nH]1
InChIInChI=1S/C24H22N6O.C24H23N5O2.C20H21N7O.C20H23N5O3/c1-2-4-17(5-3-1)15-30-16-26-22-21(19-6-7-20-18(14-19)8-9-25-20)27-24(28-23(22)30)29-10-12-31-13-11-29;1-17(30)14-18-6-5-7-19(15-18)21-22-23(27-24(26-21)28-10-12-31-13-11-28)29(16-25-22)20-8-3-2-4-9-20;1-2-13(1)10-27-12-23-18-17(14-3-4-15-16(9-14)22-11-21-15)24-20(25-19(18)27)26-5-7-28-8-6-26;26-15-5-3-4-14(12-15)17-18-19(23-20(22-17)24-7-10-27-11-8-24)25(13-21-18)16-6-1-2-9-28-16/h1-9,14,16,25H,10-13,15H2;2-9,15-16H,10-14H2,1H3;3-4,9,11-13H,1-2,5-8,10H2,(H,21,22);3-5,12-13,16,26H,1-2,6-11H2
InChIKeyWWVVGLYQFFBHMW-UHFFFAOYSA-N
MW1580.83 g/mol
LogP12.66
Rot. Bonds16

About 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one

4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one (PubChem CID 123274749) has the molecular formula C88H89N23O7 and a molecular weight of 1580.83 g/mol. Its IUPAC name is 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one.

Molecular Properties

Compound Name4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one
PubChem CID123274749
Molecular FormulaC88H89N23O7
Molecular Weight1580.83 g/mol
Exact Mass1579.73
IUPAC Name4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one
SMILESCC(=O)Cc1cccc(-c2nc(N3CCOCC3)nc3c2ncn3-c2ccccc2)c1.Oc1cccc(-c2nc(N3CCOCC3)nc3c2ncn3C2CCCCO2)c1.c1ccc(Cn2cnc3c(-c4ccc5[nH]ccc5c4)nc(N4CCOCC4)nc32)cc1.c1nc2ccc(-c3nc(N4CCOCC4)nc4c3ncn4CC3CC3)cc2[nH]1
InChIInChI=1S/C24H22N6O.C24H23N5O2.C20H21N7O.C20H23N5O3/c1-2-4-17(5-3-1)15-30-16-26-22-21(19-6-7-20-18(14-19)8-9-25-20)27-24(28-23(22)30)29-10-12-31-13-11-29;1-17(30)14-18-6-5-7-19(15-18)21-22-23(27-24(26-21)28-10-12-31-13-11-28)29(16-25-22)20-8-3-2-4-9-20;1-2-13(1)10-27-12-23-18-17(14-3-4-15-16(9-14)22-11-21-15)24-20(25-19(18)27)26-5-7-28-8-6-26;26-15-5-3-4-14(12-15)17-18-19(23-20(22-17)24-7-10-27-11-8-24)25(13-21-18)16-6-1-2-9-28-16/h1-9,14,16,25H,10-13,15H2;2-9,15-16H,10-14H2,1H3;3-4,9,11-13H,1-2,5-8,10H2,(H,21,22);3-5,12-13,16,26H,1-2,6-11H2
InChIKeyWWVVGLYQFFBHMW-UHFFFAOYSA-N
XLogP12.66
TPSA315.28 Ų
H-Bond Donors3
H-Bond Acceptors28
Rotatable Bonds16
Heavy Atoms118
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001580.83
LogP ≤ 512.66
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1028

Analyze 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one?
The IUPAC name of 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one (CID 123274749) is 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one.
What is the SMILES notation for 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one?
The canonical SMILES for 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one is CC(=O)Cc1cccc(-c2nc(N3CCOCC3)nc3c2ncn3-c2ccccc2)c1.Oc1cccc(-c2nc(N3CCOCC3)nc3c2ncn3C2CCCCO2)c1.c1ccc(Cn2cnc3c(-c4ccc5[nH]ccc5c4)nc(N4CCOCC4)nc32)cc1.c1nc2ccc(-c3nc(N4CCOCC4)nc4c3ncn4CC3CC3)cc2[nH]1.
What is the InChIKey of 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one?
The InChIKey is WWVVGLYQFFBHMW-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H22N6O.C24H23N5O2.C20H21N7O.C20H23N5O3/c1-2-4-17(5-3-1)15-30-16-26-22-21(19-6-7-20-18(14-19)8-9-25-20)27-24(28-23(22)30)29-10-12-31-13-11-29;1-17(30)14-18-6-5-7-19(15-18)21-22-23(27-24(26-21)28-10-12-31-13-11-28)29(16-25-22)20-8-3-2-4-9-20;1-2-13(1)10-27-12-23-18-17(14-3-4-15-16(9-14)22-11-21-15)24-20(25-19(18)27)26-5-7-28-8-6-26;26-15-5-3-4-14(12-15)17-18-19(23-20(22-17)24-7-10-27-11-8-24)25(13-21-18)16-6-1-2-9-28-16/h1-9,14,16,25H,10-13,15H2;2-9,15-16H,10-14H2,1H3;3-4,9,11-13H,1-2,5-8,10H2,(H,21,22);3-5,12-13,16,26H,1-2,6-11H2.
What are the key properties of 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one?
4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one has a molecular weight of 1580.83 g/mol, XLogP of 12.66, 16 rotatable bonds, 3 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[6-(3H-benzimidazol-5-yl)-9-(cyclopropylmethyl)purin-2-yl]morpholine;4-[9-benzyl-6-(1H-indol-5-yl)purin-2-yl]morpholine;3-[2-morpholin-4-yl-9-(oxan-2-yl)purin-6-yl]phenol;1-[3-(2-morpholin-4-yl-9-phenylpurin-6-yl)phenyl]propan-2-one is sourced from PubChem (CID 123274749), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).